E/ ml (15 μg/ ml) bør der tilføjes humant serumalbumin (HSA) til en slutkoncentration på 2 mg/ ml.
For patients treated with filgrastim diluted to concentrations < 1.5 MU/ ml (15 μ g/ ml), human serum albumin (HSA) should be added to a final concentration of 2 mg/ ml.